TRYPSIN II is our low-endotoxin preparation with reduced chymotrypsin activity. This can be used as an alternative to TRYPSIN IV (link). TRYPSIN II is ideally suited to the food industry, as high chymotrypsin activity can hydrolyse aromatic amino acids which contribute to food flavour profiles. This hydrolysis can impact negatively upon organoleptic properties when used in food processing, imparting an ‘off-taste’.
Applications
Trypsin has extensive applications due to its fundamental physiological function which is the same natural process as the human digestive system. Trypsin has effective uses in foods and pharmaceuticals, as well as in tissue dissociation, cell harvesting, and microbiological media. TRYPSIN II is ideally suited for functional food and food processing applications. These include improving digestibility, reducing allergenicity (particularly milk-derived casein and whey), meat tenderisation, whey protein hydrolysis, and improvement of whip and taste.
Specification
Activity reported as USP units/mg
Trypsin: ≥ 450 U/mg
Chymotrypsin: ≤ 75 U/mg
Endotoxin: ≤ 10 EU/mg
Trypsin Grades
Medical, Pharmaceutical, and Research
| Application Suitability | TRYPSIN VI | TRYPSIN IV | TRYPSIN II | TRYPSIN I | TRYPSIN 1:250 | TRYPSIN SE Pancreatin |
|---|---|---|---|---|---|---|
| Vaccine Production | ||||||
| Cell and Tissue Culture | ||||||
| Mass Spectroscopy | ||||||
| Diabetes & Ophthalmic research | ||||||
| USP / EP guideline conformance | ||||||
| Reduce Oedema and Bruising | ||||||
| Enteral Feeding |
Food Processing, Infant Formula & Dietary Supplements
| Application Suitability | TRYPSIN VI | TRYPSIN IV | TRYPSIN II | TRYPSIN I | TRYPSIN 1:250 | TRYPSIN SE Pancreatin |
|---|---|---|---|---|---|---|
| Whey Protein Hydrolysis | ||||||
| Production of Infant Formula | ||||||
| Production of Hypoallergenic Infant Formula | ||||||
| Food Processing | ||||||
| Meat and Seafood Tenderisation | ||||||
| Enhancement of Food Digestibility | ||||||
| Dietary Supplementation | ||||||
| Functional Foods |
Neova Technologies Inc., part of Bioseutica® group, has been extracting pancreatic enzymes for over 25 years. As one of the largest global manufacturers of porcine-derived enzymes, we have the experience to tailor our preparations to the exacting specifications of our customers. Contact us using the form below to discuss your specific requirements.
No Warranty: The information contained herein is provided in good faith and, to the best of our knowledge, is true and correct. However, no warranty or guarantee is implied or inferred and the information may be subject to change without prior notice. Neova Technologies Inc.’s products are sold with the understanding that the purchaser will conduct tests to determine the suitability of these products for their particular use.